While studying to identify a potential agent for androgen-independent prostate cancer patients and to investigate its biological mechanism as an antineoplastic agent, Way et al. ([2010]) demonstrated that S. involucrata effectively inhibited EGFR signaling in human hormone-resistant prostate cancer PC-3 cells. Here, EGFR is linked to prostate carcinoma.